Mark R. Brunswick
General Counsel at SORRENTO THERAPEUTICS, INC.
Profile
Mark R.
Brunswick is currently the Senior Vice President of Regulatory Affairs & Quality at Sorrento Therapeutics, Inc. He previously worked as the Director of Regulatory Affairs at Elan Biopharmaceuticals, Inc. and as the Head of Regulatory Affairs at Arena Pharmaceuticals, Inc. From 2011 to 2016, he was the Head of Regulatory Affairs & Quality at Sophiris Bio, Inc. Brunswick holds a doctorate degree from University College London.
Mark R. Brunswick active positions
| Companies | Position | Start |
|---|---|---|
| SORRENTO THERAPEUTICS, INC. | General Counsel | 2016-12-31 |
Former positions of Mark R. Brunswick
| Companies | Position | End |
|---|---|---|
| SOPHIRIS BIO | General Counsel | 2016-04-30 |
| ARENA PHARMACEUTICALS | General Counsel | - |
Elan Biopharmaceuticals, Inc.
 Elan Biopharmaceuticals, Inc. Medical DistributorsDistribution Services Elan Biopharmaceuticals, Inc. distributes drugs and pharmaceuticals. It currently distributes three concentrated morphine sulfate oral solutions which include RoxanolT CII, Roxanol-TT CII and Roxanol 100T CII. Elan Biopharmaceuticals is located in San Diego, CA. | General Counsel | - |
Training of Mark R. Brunswick
| University College London | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| SORRENTO THERAPEUTICS, INC. | Health Technology |
| Private companies | 3 |
|---|---|
Arena Pharmaceuticals, Inc.
 Arena Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Arena Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of novel drugs that target G protein-coupled receptors. It offers drugs for treatment in the field of cardiovascular, central nervous system, inflammatory, and metabolic diseases. The company was founded by Dominic P. Behan and Jack Lief on April 14, 1997 and is headquartered in Park City, UT. | Health Technology |
Sophiris Bio, Inc.
 Sophiris Bio, Inc. Pharmaceuticals: MajorHealth Technology Sophiris Bio, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of products for the treatment of urological diseases. The company was founded by James L. Heppell in May 2003 and is headquartered in La Jolla, CA. | Health Technology |
Elan Biopharmaceuticals, Inc.
Elan Biopharmaceuticals, Inc. Medical DistributorsDistribution Services Elan Biopharmaceuticals, Inc. distributes drugs and pharmaceuticals. It currently distributes three concentrated morphine sulfate oral solutions which include RoxanolT CII, Roxanol-TT CII and Roxanol 100T CII. Elan Biopharmaceuticals is located in San Diego, CA. | Distribution Services |
- Stock Market
- Insiders
- Mark R. Brunswick
